Urological Research

, Volume 27, Issue 5, pp 351–356

Experimental autoimmune cystitis: further characterization and serum autoantibodies

  • Sankar Mitra
  • Abraham Dagher
  • Reinhard Kage
  • Rifaat K. Dagher
  • Judith Luber-Narod
ORIGINAL PAPER

DOI: 10.1007/s002400050162

Cite this article as:
Mitra, S., Dagher, A., Kage, R. et al. Urological Research (1999) 27: 351. doi:10.1007/s002400050162

Abstract

Previously, we described an animal model for interstitial cystitis (IC), experimental autoimmune cystitis (EAC) [Luber-Narod et al. Urol Res 24:367]. Further characterization of animals with EAC indicates that peak and mean urinary frequency are elevated compared with sham-injected controls and that the disease progresses with at least two cycles of exacerbations and remissions. We had shown evidence suggesting EAC to be autoimmune in nature. In this paper, we identify serum autoantibodies from 9/10 EAC animals which bind to a protein specific to rat bladder with a relative molecular weight of 12-kDa. Such autoantibodies are absent in 12/13 normal and sham-injected animals as well as animals which fail to develop EAC despite disease induction. These findings suggest that EAC is a reproducible model of cyclical increases of urinary frequency, and that a 12-kDa antigen is the target of autoantibodies which correlate with those elevations. Identification of this target antigen may explain the pathogenesis of increased urinary frequency in these animals and potentially in IC as well.

Key words Interstitial cystitis Animal models Autoantibodies Urinary frequency Autoimmunity 
Download to read the full article text

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Sankar Mitra
    • 1
  • Abraham Dagher
    • 1
  • Reinhard Kage
    • 2
  • Rifaat K. Dagher
    • 3
  • Judith Luber-Narod
    • 1
  1. 1.Department of Surgery/Urology, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USAUS
  2. 2.National Institute of Allergy and Infectious Disease, NIH, Bethesda, MD, USAUS
  3. 3.Henry Ford Hospital, Detroit, MI, USAUS

Personalised recommendations